Skip to main content

Advertisement

Table 2 Quality of life baseline scores as measured by the EORTC QLQ-C30 for each study arms

From: Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

  ECF group TCF group P
  Mean (SD) Mean (SD)  
Functioning scores*    
Physical functioning 65.3 (13.4) 66.1 (11.1) 0.79
Role functioning 68.5 (15.5) 68.0 (18.4) 0.89
Emotional functioning 64.0 (12.1) 56.6 (14.7) 0.02
Cognitive functioning 85.7 (10.8) 84.2 (14.3) 0.61
Social functioning 68.1 (13.6) 68.5 (13.1) 0.89
Global quality of life 55.2 (17.4) 45.1 (14.4) 0.01
Symptom scores**    
Fatigue 43.5 (14.8) 49.6 (17.3) 0.11
Nausea and vomiting 22.8 (19.8) 33.8 (23.7) 0.04
Pain 40.0 (16.7) 47.1 (21.2) 0.12
Dyspnoea 7.62 (16.3) 12.0 (21.3) 0.33
Sleep difficulties 31.4 (25.5) 40.7 (21.2) 0.09
Appetite loss 39.0 (22.1) 46.3 (24.3) 0.19
Constipation 14.3 (21.8) 14.8 (26.9) 0.93
Diarrhoea 3.81 (10.7) 9.25 (18.8) 0.14
Financial difficulties 52.4 (20.2) 44.4 (21.1) 0.11
  1. * Higher scores show better functioning and global quality of life.
  2. ** Higher scores indicate greater symptoms.